Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hohmann, US

Andrea Hohmann, Athens, GA US

Patent application numberDescriptionPublished
20090082435Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders - Methods, compositions, and compounds for inhibiting monoacyglycerol lipase, and for treating pain, for modulating stress-induced analgesia or for treating stress-induced disorders in mammals are provided.03-26-2009

Andrea G. Hohmann, Bloomington, IN US

Patent application numberDescriptionPublished
20110280807Methods and Models for Stress-Induced Analgesia - The invention disclosed relates to methods and models for enhancing stress-induced analgesia through non-opioid mechanisms.11-17-2011

Andreas Hohmann, Watertown, MA US

Patent application numberDescriptionPublished
20090210748METHODS AND SYSTEMS TO TEST AIRLINE INFORMATION SYSTEMS - Methods and systems to simulated a plurality of airline information systems (AISs) to test an AIS under test (AISUT), including to send and receive messages between the simulated AISs, and to send messages to and receive messages from the AISUT, in accordance with communication parameters associated with the corresponding AISs and AISUT. The AISUT and/or the simulated AISs may be stimulated to cause interaction with the AISUT, and resultant messages and information may be recorded. Stimulation may include controlling a web browser to interact with a web application of the AISUT. AISs may be represented as travel system objects, which may be associated with corresponding AIS-specific message handling and reporting parameters. Message processing logic may be configured to process messages, such as booking request messages, directed to a plurality of the simulated AISs, and the travel systems and the message processing logic may be modifiable independent of one another.08-20-2009

John Hohmann, Seattle, WA US

Patent application numberDescriptionPublished
20100113486USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS - A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act.05-06-2010
20110091388USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS - A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act.04-21-2011
20110185439G PROTEIN COUPLED RECEPTORS AND USES THEREOF - The present invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, as well as methods for their production. The polypeptides and polynucleotides are useful, for example, in methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g., agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention, and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR activity or levels.07-28-2011

John Hohmann, La Conner, WA US

Patent application numberDescriptionPublished
20080260744G PROTEIN COUPLED RECEPTORS AND USES THEREOF - The present invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, as well as methods for their production. The polypeptides and polynucleotides are useful, for example, in methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g., agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention, and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR activity or levels.10-23-2008
20090178153G PROTEIN COUPLED RECEPTORS AND USES THEREOF - The present invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, as well as methods for their production. The polypeptides and polynucleotides are useful, for example, in methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g., agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention, and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR activity or levels.07-09-2009
20110214189G PROTEIN COUPLED RECEPTORS AND USES THEREOF - The present invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, as well as methods for their production. The polypeptides and polynucleotides are useful, for example, in methods of diagnosis and treatment of diseases and disorders. The invention also provides methods for identifying compounds (e.g., agonists or antagonists) using the GPCR polypeptides and polynucleotides of the invention, and for treating conditions associated with GPCR dysfunction with the GPCR polypeptides, polynucleotides, or identified compounds. The invention also provides diagnostic assays for detecting diseases or disorders associated with inappropriate GPCR activity or levels.09-01-2011

Patent applications by John Hohmann, La Conner, WA US

John Hohmann, Laconner, WA US

Patent application numberDescriptionPublished
20080260643USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS - A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act.10-23-2008

Luke H. Hohmann, Sunnyvale, CA US

Patent application numberDescriptionPublished
20120088561Systems and Methods for Scoring Familiarity - Systems and methods for scoring familiarity are disclosed. In some embodiments, a method comprises selecting a topic by a first user, presenting items associated with the topic to the first user, ranking a first set of the items by the first user, presenting the items to a second user, ranking a second set of the items by the second user, and scoring the second ranking relative to the first ranking.04-12-2012

Mark Hohmann, San Francisco, CA US

Patent application numberDescriptionPublished
20080301045SYSTEM AND METHOD FOR FACILITATING ENGAGEMENT AND COMMUNICATION BETWEEN A COMPANY AND A RECRUITING FIRM - A system to facilitate engagement and communication between a company with an available position and at least one recruiter includes a server coupled to a computer network, a user interface for co-workers at the company coupled to the server over the computer network and a plurality of co-workers post information to the server about an available position of the company, including a bounty, receive information from the server about candidates for the available position of the company, and select a candidate on the server for the available position, and a user interface for recruiters coupled to the server over the computer network and a plurality of recruiters receive information from the server about an available position of the company and submit information to the server about a candidate for the position of the company.12-04-2008
20090125379METHOD TO FACILITATE ENGAGEMENT AND COMMUNICATION BETWEEN A COMPANY AND A RECRUITER INCLUDING A BOUNTY - The present invention includes a method to facilitate engagement and communication between a company with an available position and a recruiter. The method includes the steps of posting information about the available position for the company, and receiving information about a candidate for the available position of the company from the recruiter, and submitting the information about the candidate for the available position of the company to the company. The method further includes the step of receiving payment from the company and transmitting a portion of the payment to the recruiter upon the selection by the company of a candidate for the available position.05-14-2009
20090125443METHOD TO FACILITATE ENGAGEMENT AND COMMUNICATION BETWEEN A COMPANY AND A RECRUITER - The present invention includes a method to facilitate engagement and communication between a company with an available position and a recruiter. The method includes the steps of posting information about the available position for the company, and receiving information about a candidate for the available position of the company from the recruiter, and submitting the information about the candidate for the available position of the company to the company. The method further includes the step of receiving payment from the company and transmitting a portion of the payment to the recruiter upon the selection by the company of a candidate for the available position.05-14-2009

Ronald P. Hohmann, Hauppauge, NY US

Patent application numberDescriptionPublished
20100101175LOCKING CONCRETE INSERT - A locking insert is described for use in a poured concrete structure. The locking insert includes a hollow elongated body, a longitudinal channel with two configured side edges and a channel floor, a paired gear nut and locking plate that interengages said configured side edges, an attachment bolt, and a method to prevent concrete from seeping into the locking insert. The embedment of the locking insert into a concrete structure provides a positive locking, positional and anti-slip method of attachment for a structural or secondary element. The locking insert allows for vertical positioning and locking of the paired gear nut and locking plate to ensure a proper connection with a structural or secondary element through an attachment bolt. The locking insert with an attached outwardly projecting element transfers the load associated with the structural or secondary element throughout the concrete structure to allow for a high strength connection.04-29-2010

Patent applications by Ronald P. Hohmann, Hauppauge, NY US

Stephen Hohmann, Dallas, TX US

Patent application numberDescriptionPublished
20110295181IMPLANTABLE AND REMOVABLE CUSTOMIZABLE BODY CONDUIT - An apparatus and method are provided to treat a stenosis. A delivery device is provided that has an elongate tubular member coupled therewith. The elongate tubular member has an outside surface that is configured to prevent adherence of in vivo matter. The tubular member has a proximal end and a distal end and is reinforced along its length to maintain open lumen under a transverse load. The tubular member is placed in the vasculature such that the distal end of the elongate tubular member is disposed distal of a stenosis. The proximal end of the elongate tubular member is disposed inside the vessel, preferably at a location proximal of the stenosis. Thereafter, after a therapeutic period, the elongate tubular member is removed intact.12-01-2011

Susanna Marie Hohmann, Portland, OR US

Patent application numberDescriptionPublished
20120015783Quick Deploy Drag Chute - Embodiments relate to a drag chute. An exemplary drag chute is comprised of a canopy from flexible material having a perimeter, a first surface, and a second surface. The drag chute is also comprised of a stiffening member coupled to the canopy along a portion of the canopy perimeter. The drag chute is also comprised of a veil attached to the canopy and a leash attached to the veil. The stiffening member may be maintained in a tunnel that extends along at least a portion of the canopy perimeter. In an additional embodiment, the stiffening member may be a foam material. An additional embodiment may include an integrated bag for storing one or more parts of the drag chute when not in use.01-19-2012